Adial Pharmaceuticals ADIL
NASDAQ ADIL
$4.12 -0.01 (-0.24%)
At close: Oct 2, 2026 · 4:00 PM EDT

Adial Pharmaceuticals (ADIL) Return on Capital Employed [ROCE] (2018 - 2026)

Updated

Adial Pharmaceuticals' Return on Capital Employed [ROCE] came in at -479.15% for Q2 2026, down 267.13 percentage points from -212.02% a year earlier and down 309.51 percentage points from the prior quarter.

Analysis

Adial Pharmaceuticals (ADIL) Return on Capital Employed [ROCE] (2018 - 2026) Analysis & Trends

For FY2025, Adial Pharmaceuticals' Return on Capital Employed [ROCE] was -174.80%, up 36.84 percentage points from FY2024.

  • Return on Capital Employed [ROCE] carries a five-year change of +40.31 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Capital Employed [ROCE] was -211.64% in FY2024 (-61.30 pp), -150.34% in FY2023 (+75.29 pp), -225.63% in FY2022 (+287.26 pp) and -512.89% in FY2021 (-297.78 pp).
  • The Q2 2026 figure represents the lowest quarterly Return on Capital Employed [ROCE] in data going back to Q3 2018.
  • Year-over-year, Return on Capital Employed [ROCE] increased in five of the last eight quarters, with an average year-over-year change of -25.72 percentage points.
  • The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q1 2024 (a gain of 227.64 percentage points), and the weakest in Q2 2026 (a drop of 267.13 percentage points).
  • Business Quant data shows ADIL's Return on Capital Employed [ROCE] at -169.64% (Q1 2026), -163.50% (Q4 2025) and -154.73% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Adial Pharmaceuticals 19.04 Mn 19.04 Mn - -479.15%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -479.15%
Mar 31, 2026 -169.64%
Dec 31, 2025 -163.50%
Sep 30, 2025 -154.73%
Jun 30, 2025 -212.02%
Mar 31, 2025 -297.86%
Dec 31, 2024 -168.99%
Sep 30, 2024 -162.50%
Jun 30, 2024 -141.39%
Mar 31, 2024 -125.57%
Dec 31, 2023 -218.74%
Sep 30, 2023 -275.55%
Jun 30, 2023 -263.38%
Mar 31, 2023 -353.21%
Dec 31, 2022 -231.58%
Sep 30, 2022 -185.35%
Jun 30, 2022 -154.56%
Mar 31, 2022 -204.81%
Dec 31, 2021 -309.20%
Sep 30, 2021 -229.94%
API Access

Adial Pharmaceuticals Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ADIL&period=max&api_key=YOUR_API_KEY